Clinical Trials for Bladder Cancer (TCC)
Transitional cell carcinoma (TCC) is the most common bladder cancer in dogs and cats, arising from the transitional epithelium of the urinary tract. In dogs it particularly affects Scottish Terriers, Beagles, and Shetland Sheepdogs. Clinical trials at accredited veterinary universities are investigating targeted therapies, immunotherapy, and new drug combinations that may be available at reduced or no cost.
Check back soon — new trials open frequently
Trials available at institutions in:
Get notified when Bladder Cancer (Transitional Cell Carcinoma - TCC) trials open
Our matching service monitors all Bladder Cancer (Transitional Cell Carcinoma - TCC) trials nationwide and will notify you the moment one opens.
$7 to see your matches · $23 only if trials are found
Join the Waitlist →Find Trials for Your Pet
Our free matching service screens 141+ active trials at 25 accredited veterinary universities. Submit once, get matched to every relevant trial.
Find Trials for Your Pet